Archive for May 12th, 2010

Workers pulled out of the Gulf of Mexico when BP’s Deepwater Horizon oil rig exploded last month were greeted by employees from the drilling contractor Transocean with waivers stating that they were not injured in the explosion.

The waivers required workers to state what they were doing at the time of the explosion and state that they were not witnesses to the incident requiring evacuation.

One worker, Chris Choy, told PBS News Hour that “I had been up for almost 40 hours, and just gone through hell. And they want to throw papers in my face for me to sign to take them, you know, out of their responsibility.”

Public Citizen has already pointed out serious problems with BP’s safety record, showing that it repeatedly put workers in dangerous situations.  Just last year, OSHA issued the largest penalty ever – $87.4 million – for failing to fix violations for which it had previously been cited.

But despite multi-million dollar penalties from multiple agencies, BP continued to put its workers in danger.  Last week, Senators Rockefeller and Byrd introduced two amendments to the financial reform bill that would make BP and other companies accountable to shareholders and the public for workplace safety violations.  These amendments would require disclosure of workplace safety violations in a report filed with the Securities and Exchange Commission (SEC).

Lena Pons is a policy analyst for Public Citizen.

We’ve written about the dangers of the diabetes drug Avandia and have told Congress about an unethical international clinical trial, requested by the FDA, being performed by Avandia’s manufacturer, GlaxoSmithKline.

Now Public Citizen and Canadian researcher/physician David Juurlink go straight to the source, sending a letter to FDA Commissioner Margaret Hamburg asking her to halt the study, which pits Avandia against its competitor, Actos.

From the Reuters story:

“A wealth of data now suggests” that Avandia carries greater risks than Actos, the researchers said. Patients are also not adequately informed about the safety differences between the two medicines when deciding whether to participate in the trial, they added.

But FDA officials, who have said they are already taking a closer look at Avandia, are not likely to act so quickly.

And the Los Angeles Times:

In act, both drugs [Avandia and Actos] have been tagged with safety issues: In addition to raising rates of cardiovascular events, the class of Type 2 diabetes drugs known as thiazolidinediones (or TZDs) have been linked in studies to higher rates of edema, macular edema, bony fractures, anemia and acute liver injury. Older diabetes medicine such as metformin and sulfonylurea are widely believed to be safer alternatives.

But to no avail — the FDA likely won’t examine the study until July, FiercePharma reports.

Holman

Sophists have long known that when you cannot defeat a proposal based on merit, then resort to groundless – or even false – accusations to create hysteria and confusion over the proposal.

Those opposed to the recent health care reform legislation did exactly that when they invented the myth that the legislation would create the infamous “death panels” – government health officials ready and eager to pull the plug on granny when she gets too old. It was nonsense, of course. There was nothing in the legislation that would create death panels. But that wasn’t the point. The point was to spread hysteria and confusion about the legislation in order to defeat it.

We are now hearing some of the same sophistry from opponents of the DISCLOSE Act (H.R. 5175), legislation in response to the Citizens United decision, in which the Court ruled that corporations may make unlimited expenditures in elections. The DISCLOSE Act is a good but modest bill designed to open the books on who is paying for these unlimited independent expenditure campaign ads.

Continue Reading

After half a year of delay, Sens. John Kerry (D-Mass.) and Joe Lieberman (I-Conn.) are set to release their nuclear energy/cap-and-trade bill today. Until we see legislative text, we can comment only on the broad outline made available yesterday and an additional summary being circulated among legislative staff.

It’s not accurate to call this a climate bill. This is nuclear energy-promoting, oil drilling-championing, coal mining-boosting legislation with a weak carbon-pricing mechanism thrown in. What’s worse, it guts the Environmental Protection Agency’s (EPA) current authority to regulate greenhouse gases as pollutants under the Clean Air Act.

Here’s our take on what we know is in the new bill:

Continue Reading

© Copyright . All Rights Reserved.